Heart transplantation in patients with eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome)

Journal of Heart and Lung Transplantation

Volumn 33, Issue 8, 2014, Pages 842-850

  Groh, Matthieu ^a   Masciocco, Gabriella ^b   Kirchner, Elizabeth ^c   Kristen, Arnt ^d   Pellegrini, Carlo ^e   Varnous, Shaïda ^f   Bortman, Guillermo ^g   Rosenberg, Mark ^h   Brucato, Antonio ⁱ   Waterworth, Paul ^j   Bonacina, Edgardo ^b   Facchetti, Fabio ^k   Calabrese, Leonard ^c   Gregorini, Gina ^l   Scali, Juan Jose ^m   Starling, Randall ^c   Frigerio, Maria ^b   D'Armini, Andrea Maria ^e   Guillevin, Loïc ^f  

^a Hôpital Cochin ^*  (France)

^b OSPEDALE NIGUARDA CA GRANDA   (Italy)

^c LERNER RESEARCH INSTITUTE   (United States)

^d UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^e UNIVERSITY OF PAVIA   (Italy)

^f PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^g Sanatorio de la Trinidad   (Argentina)

^h UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

ⁱ PAPA GIOVANNI XXIII HOSPITAL   (Italy)

^j WYTHENSHAWE HOSPITAL   (United Kingdom)

^k UNIVERSITY OF BRESCIA   (Italy)

^l SPEDALI CIVILI   (Italy)

^m HOSPITAL DURAND   (Argentina)

more..

Author keywords

asthma; cardiac arrhythmias; cardiomyopathy; Churg Strauss; heart transplantation; hypereosinophilic syndrome; immunosuppression; myocarditis; syndrome

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; LEVOSIMENDAN; NEUTROPHIL CYTOPLASMIC ANTIBODY; TROPONIN I;

ADULT; ANCA ASSOCIATED VASCULITIS; ANTIBODY MEDIATED REJECTION; ARTICLE; ASTHMA; CARDIAC GRAFT REJECTION; CARDIOMYOPATHY; CARDIOVASCULAR MAGNETIC RESONANCE; CHURG STRAUSS SYNDROME; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CORTICOSTEROID THERAPY; DAILY LIFE ACTIVITY; DISEASE ACTIVITY; DISEASE SEVERITY; EOSINOPHIL COUNT; EXPLANT; FEMALE; FOLLOW UP; GRAFT INFECTION; GRANULOMATOSIS WITH POLYANGIITIS EOSINOPHILIC RELATED CARDIOMYOPATHY; HEART LEFT VENTRICLE EJECTION FRACTION; HEART TRANSPLANTATION; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INTRAAORTIC BALLOON PUMP; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SINUSITIS; SUDDEN CARDIAC DEATH; SURVIVAL RATE; VENTRICULAR ASSIST DEVICE; YOUNG ADULT; ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; CARDIOMYOPATHIES; CHURG-STRAUSS SYNDROME; CLINICAL TRIAL; COMPLICATION; HEART MUSCLE; MORTALITY; MULTICENTER STUDY; PATHOLOGY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

ADULT; ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; CARDIOMYOPATHIES; CHURG-STRAUSS SYNDROME; FEMALE; HEART TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84905114521     PISSN: 10532498     EISSN: 15573117     Source Type: Journal    
DOI: 10.1016/j.healun.2014.02.023     Document Type: Article

References (49)

1. Jennette J, Falk R, Bacon P, et al. 2012 Revised International Chapel Hill Consensus Conference Nomenclature of vasculitides. Arthritis Rheum 2013;65:1-11.
2. G. Haugeberg, R. Bie, and A. Bendvold et al. Primary vasculitis in a Norwegian community hospital: a retrospective study Clin Rheumatol 17 1998 364 368
3. A. Mahr, L. Guillevin, and M. Poissonnet et al. Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener's granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: a capture-recapture estimate Arthritis Rheum 51 2004 92 99
4. E. Reinhold-Keller, K. Herlyn, and R. Wagner-Bastmeyer et al. NO difference in the incidences of vasculitides between north and south Germany: first results of the German vasculitis register Rheumatol Oxf Engl 41 2002 540 549
5. R.M. Martin, L.V. Wilton, and R.D. Mann Prevalence of Churg-Strauss syndrome, vasculitis, eosinophilia and associated conditions: retrospective analysis of 58 prescription-event monitoring cohort studies Pharmacoepidemiol Drug Saf 8 1999 179 189
6. L.R. Harrold, S.E. Andrade, and A.S. Go et al. Incidence of Churg-Strauss syndrome in asthma drug users: a population-based perspective J Rheumatol 32 2005 1076 1080
7. J.E. Loughlin, J.A. Cole, and K.J. Rothman et al. Prevalence of serious eosinophilia and incidence of Churg-Strauss syndrome in a cohort of asthma patients Ann Allergy Asthma Immunol 88 2002 319 325
8. C. Comarmond, C. Pagnoux, and M. Khellaf et al. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome): clinical characteristics and long-term follow-up of the 383 patients enrolled in the FVSG cohort Arthritis Rheum 65 2013 270 281
9. R.A. Sinico, L. Di Toma, and U. Maggiore et al. Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome Arthritis Rheum 52 2005 2926 2935
10. B. Healy, S. Bibby, and R. Steele et al. Antineutrophil cytoplasmic autoantibodies and myeloperoxidase autoantibodies in clinical expression of Churg-Strauss syndrome J Allergy Clin Immunol 131 2013 571 576
11. F. Moosig, J.P. Bremer, and B. Hellmich et al. A vasculitis centre based management strategy leads to improved outcome in eosinophilic granulomatosis and polyangiitis (Churg-Strauss, EGPA): monocentric experiences in 150 patients Ann Rheum Dis 72 2013 1011 1017
12. R.M. Dennert, P. van Paassen, and S. Schalla et al. Cardiac involvement in Churg-Strauss syndrome Arthritis Rheum 62 2010 627 634
13. J. Marmursztejn, L. Guillevin, and R. Trebossen et al. Churg-Strauss syndrome cardiac involvement evaluated by cardiac magnetic resonance imaging and positron-emission tomography: a prospective study on 20 patients Rheumatology (Oxford) 52 2013 642 650
14. J. Marmursztejn, O. Vignaux, and P. Cohen et al. Impact of cardiac magnetic resonance imaging for assessment of Churg-Strauss syndrome: a cross-sectional study in 20 patients Clin Exp Rheumatol 27 suppl 2009 S70 S76
15. T. Neumann, B. Manger, and M. Schmid et al. Cardiac involvement in Churg-Strauss syndrome Medicine (Baltimore) 88 2009 236 243
16. C. Pagnoux, and L. Guillevin Cardiac involvement in small and medium-sized vessel vasculitides Lupus 14 2005 718 722
17. G. Pelà, G. Tirabassi, and P. Pattoneri et al. Cardiac involvement in the Churg-Strauss syndrome Am J Cardiol 97 2006 1519 1524
18. L. Guillevin, F. Lhote, and M. Gayraud et al. Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients Medicine (Baltimore) 75 1996 17 28
19. L. Guillevin, C. Pagnoux, and R. Seror et al. The Five-Factor Score revisited Medicine (Baltimore) 90 2011 19 27
20. P. Cohen, C. Pagnoux, and A. Mahr et al. Churg-Strauss syndrome with poor-prognosis factors: a prospective multicenter trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in forty-eight patients Arthritis Rheum 57 2007 686 693
21. M.R. Mehra, J. Kobashigawa, and R. Starling et al. Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates-2006 J Heart Lung Transplant 25 2006 1024 1042
22. R.A. Henderson, P. Hasleton, and B.N. Hamid Recurrence of Churg Strauss vasculitis in a transplanted heart Heart 70 1993 553
23. A.T. Masi, G.G. Hunder, and J.T. Lie et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis) Arthritis Rheum 33 1990 1094 1100
24. M.E. Billingham, N.R. Cary, and M.E. Hammond et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection J Heart Transplant 9 1990 587 593
25. S. Stewart, G.L. Winters, and M.C. Fishbein et al. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection J Heart Lung Transplant 24 2005 1710 1720
26. G.J. Berry, A. Angelini, and M.M. Burke et al. The ISHLT working formulation for pathologic diagnosis of antibody-mediated rejection in heart transplantation: evolution and current status (2005-2011) J Heart Lung Transplant 30 2011 601 611
27. C. Mukhtyar, R. Lee, and D. Brown et al. Modification and validation of the Birmingham Vasculitis Activity Score (version 3) Ann Rheum Dis 68 2009 1827 1832
28. A.R. Exley, P.A. Bacon, and R.A. Luqmani et al. Development and initial validation of the Vasculitis Damage Index for the standardized clinical assessment of damage in the systemic vasculitides Arthritis Rheum 40 1997 371 380
29. C. Mukhtyar, L. Guillevin, and M.C. Cid et al. EULAR recommendations for the management of primary small and medium vessel vasculitis Ann Rheum Dis 68 2009 310 317
30. C. Mukhtyar, O. Flossmann, and B. Hellmich et al. Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism Systemic Vasculitis Task Force Ann Rheum Dis 67 2008 1004 1010
31. M.R. Mehra, M.G. Crespo-Leiro, and A. Dipchand et al. International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy J Heart Lung Transplant 29 2010 717 727
32. D. Corradi, R. Maestri, and F. Facchetti Postpartum Churg-Strauss syndrome with severe cardiac involvement: description of a case and review of the literature Clin Rheumatol 28 2009 739 743
33. M. Rosenberg, H.M. Lorenz, and N. Gassler et al. Rapid progressive eosinophilic cardiomyopathy in a patient with Churg-Strauss syndrome (CSS) Clin Res Cardiol 95 2006 289 294
34. D. Thomson, H. Chamsi-Pasha, and P. Hasleton Heart transplantation for Churg-Strauss syndrome Heart 62 1989 409 410
35. H. Baccouche, A. Yilmaz, and D. Alscher et al. Images in cardiovascular medicine. Magnetic resonance assessment and therapy monitoring of cardiac involvement in Churg-Strauss syndrome Circulation 117 2008 1745 1749
36. P.-Y. Courand, P. Croisille, and C. Khouatra et al. Churg-Strauss syndrome presenting with acute myocarditis and cardiogenic shock Heart Lung Circ 21 2012 178 181
37. L.T. Cooper, K.L. Baughman, and A.M. Feldman et al. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology Eur Heart J 28 2007 3076 3093
38. S. Kanai-Yoshizawa, and T. Sugiyama Kato et al. Hypersensitivity myocarditis and outcome after heart transplantation J Heart Lung Transplant 32 2013 553 559
39. S. Yoshizawa, T.S. Kato, and D. Mancini et al. Outcome of patients having heart transplantation for lymphocytic myocarditis Am J Cardiol 112 2013 405 410
40. N. Tweezer-Zaks, G. Zandman-Goddard, and M. Lidar et al. A long-term follow-up after cardiac transplantation in a lupus patient: case report and review of the literature Ann NY Acad Sci 1110 2007 539 543
41. C. Camacho Vazquez, L. Alonso Pulpon, and C. Maicas Bellido et al. Heart transplantation in a patient with rheumatoid arthritis Rev Esp Cardiol 50 1997 357 359
42. R. Saggar, D. Khanna, and D.E. Furst et al. Systemic sclerosis and bilateral lung transplantation: a single centre experience Eur Respir J 36 2010 893 900
43. E. Martens, P. Lange, and T. Pohl et al. Heart transplantation in a 36-year-old experiencing terminal heart failure caused by systemic sclerosis Transplantation 94 2012 e13 e15
44. M. Grimm, M. Rinaldi, and N.A. Yonan et al. Superior prevention of acute rejection by tacrolimus vs. cyclosporine in heart transplant recipients-a large European trial Am J Transplant 6 2006 1387 1397
45. L. Penninga, C.H. Møller, and F. Gustafsson et al. Tacrolimus versus cyclosporine as primary immunosuppression after heart transplantation: systematic review with meta-analyses and trial sequential analyses of randomised trials Eur J Clin Pharmacol 66 2010 1177 1187
46. S. Niiyama, Y. Amoh, and K. Suzuki et al. Efficacy of tacrolimus against Churg-Strauss syndrome in a patient with myasthenia gravis Rheumatol Int 30 2010 847 848
47. H.J. Eisen, J. Kobashigawa, and A. Keogh et al. Three-year results of a randomized, double-blind, controlled trial of mycophenolate mofetil versus azathioprine in cardiac transplant recipients J Heart Lung Transplant 24 2005 517 525
48. T.F. Hiemstra, M. Walsh, and A. Mahr et al. Mycophenolate mofetil vs azathioprine for remission maintenance in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized controlled trial JAMA 304 2010 2381 2388
49. M.R. Costanzo, A. Dipchand, and R. Starling et al. The International Society for Heart and Lung Transplantation Guidelines for the care of heart transplant recipients J Heart Lung Transplant 29 2010 914 956